Voyager Therapeutics, Inc.
A biotechnology company developing proprietary adeno-associated virus (AAV)-based gene therapy drugs to treat neurological and other diseases with high unmet medical needs. The company is developing treatments for Alzheimer's disease, amyotrophic lateral sclerosis (ALS), Friedreich's ataxia, Parkinson's disease, and more. Delaware-based
Overview
Overview | |
|---|---|
Country | United States |
State | Massachusetts |
Employees | 162 |
Founded | 2013 |
Financials | |
|---|---|
Market Capitalization | 477.03M |
Revenue | 119.04M |
Operating Income | -17.05M |
Operating Margin | -14.32% |
Net Income | -3.04M |
Ranking
Operating Income
Operating Income Ranking | |
|---|---|
All | 3876 / 5373 |
Sector : Healthcare | 459 / 1144 |
Industry : Biotechnology | 159 / 645 |
Market Capitalization
Market Capitalization Ranking | |
|---|---|
All | 3033 / 5565 |
Sector : Healthcare | 451 / 1182 |
Industry : Biotechnology | 214 / 670 |
Net Income
Net Income Ranking | |
|---|---|
All | 3084 / 5436 |
Sector : Healthcare | 222 / 1164 |
Industry : Biotechnology | 50 / 659 |
Employees
Employees Ranking | |
|---|---|
All | 3690 / 5330 |
Sector : Healthcare | 507 / 1174 |
Industry : Biotechnology | 169 / 667 |